Back

Tendon Cell Deletion of IKKβ/NF-κB Drives Functionally Deficient Tendon Healing and Altered Cell Survival Signaling In Vivo

Best, K. T.; Knapp, E.; Ketonis, C.; Jonason, J. H.; Awad, H. A.; Loiselle, A. E.

2020-03-04 molecular biology
10.1101/2020.03.03.974774 bioRxiv
Show abstract

Acute tendon injuries are characterized by excessive matrix deposition that impedes regeneration and disrupts functional improvements. Inflammation is postulated to drive pathologic scar tissue formation, with nuclear factor kappa B (NF-{kappa}B) signaling emerging as a candidate pathway in this process. However, characterization of the spatial and temporal activation of canonical NF-{kappa}B signaling during tendon healing in vivo, including identification of the cell populations activating NF-{kappa}B, is currently unexplored. Therefore, we aimed to determine which cell populations activate canonical NF-{kappa}B signaling following flexor tendon repair with the goal of delineating cell-specific functions of NF-{kappa}B signaling during scar mediated tendon healing. Immunofluorescence revealed that both tendon cells and myofibroblasts exhibit prolonged activation of canonical NF-{kappa}B signaling into the remodeling phase of healing. Using cre-mediated knockout of the canonical NF-{kappa}B kinase (IKK{beta}), we discovered that suppression of canonical NF-{kappa}B signaling in Scleraxis-lineage cells increased myofibroblast content and scar tissue formation. Interestingly, Scleraxis-lineage specific knockout of IKK{beta} increased the incidence of apoptosis, suggesting that canonical NF-{kappa}B signaling may be mediating cell survival during tendon healing. These findings suggest indispensable roles for canonical NF-{kappa}B signaling during flexor tendon healing. One Sentence SummaryScleraxis-lineage specific knockdown of persistent canonical IKK{beta}/NF-{kappa}B drives scar formation and apoptotic signaling during flexor tendon healing.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
The FASEB Journal
175 papers in training set
Top 0.1%
22.5%
2
Arthritis & Rheumatology
33 papers in training set
Top 0.1%
6.3%
3
JCI Insight
241 papers in training set
Top 0.5%
6.3%
4
International Journal of Molecular Sciences
453 papers in training set
Top 3%
3.6%
5
Scientific Reports
3102 papers in training set
Top 37%
3.6%
6
PLOS ONE
4510 papers in training set
Top 42%
3.2%
7
Matrix Biology
28 papers in training set
Top 0.1%
3.1%
8
eLife
5422 papers in training set
Top 30%
2.9%
50% of probability mass above
9
Stem Cell Research & Therapy
30 papers in training set
Top 0.2%
2.9%
10
Disease Models & Mechanisms
119 papers in training set
Top 0.6%
2.7%
11
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.2%
2.1%
12
Cell Death Discovery
51 papers in training set
Top 0.4%
2.1%
13
Journal of Virology
456 papers in training set
Top 2%
1.3%
14
Journal of Investigative Dermatology
42 papers in training set
Top 0.4%
1.3%
15
Nature Communications
4913 papers in training set
Top 56%
1.2%
16
Osteoarthritis and Cartilage
30 papers in training set
Top 0.3%
1.1%
17
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
0.9%
18
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
19
PLOS Pathogens
721 papers in training set
Top 8%
0.9%
20
Frontiers in Immunology
586 papers in training set
Top 6%
0.9%
21
Cell Reports
1338 papers in training set
Top 30%
0.9%
22
Aging Cell
144 papers in training set
Top 3%
0.8%
23
Experimental Physiology
19 papers in training set
Top 0.5%
0.7%
24
iScience
1063 papers in training set
Top 32%
0.7%
25
Cells
232 papers in training set
Top 7%
0.7%
26
PeerJ
261 papers in training set
Top 16%
0.7%